The Current Ratio as of November 2024 (TTM) for Agenus Inc. (AGEN) is 0.19

According to Agenus Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.19. This represents a change of -39.73% compared to the average of 0.31 of the last 4 quarters.

Agenus Inc. (AGEN) Historical Current Ratio (quarterly & annually)

How has AGEN Current Ratio performed in the past?

The mean historical Current Ratio of Agenus Inc. over the last ten years is 2.09. The current 0.19 Current Ratio has changed 787.09% with respect to the historical average. Over the past ten years (40 quarters), AGEN's Current Ratio was at its highest in in the September 2015 quarter at 7.39. The Current Ratio was at its lowest in in the September 2024 quarter at 0.19.

Agenus Inc. (AGEN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Agenus Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Agenus Inc. (AGEN) Average Current Ratio

How has AGEN Current Ratio performed in the past?

The current Current Ratio of Agenus Inc. (AGEN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Agenus Inc. (AGEN) Current Ratio vs. Peers

How is AGEN’s Current Ratio compared to its peers?

Agenus Inc.’s Current Ratio is less than Icosavax, Inc. (18.06), less than Galera Therapeutics, Inc. (5.63), less than Marker Therapeutics, Inc. (3.15), less than Edgewise Therapeutics, Inc. (26.35), less than Adaptimmune Therapeutics plc (3.85), less than Mereo BioPharma Group plc (6.10), less than Pieris Pharmaceuticals, Inc. (4.82), greater than PDS Biotechnology Corporation (0.00), less than Leap Therapeutics, Inc. (3.97), less than Viking Therapeutics, Inc. (36.47), less than TG Therapeutics, Inc. (4.59), less than X4 Pharmaceuticals, Inc. (4.89), less than Madrigal Pharmaceuticals, Inc. (5.98), less than TCR2 Therapeutics Inc. (2.77), less than Affimed N.V. (1.93), less than ADC Therapeutics SA (4.92),

Build a custom stock screener for Agenus Inc. (AGEN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Agenus Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Agenus Inc. (AGEN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Agenus Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.